A5107534369- Metabolism, Diabetes, and Cancer
- Liver Disease Diagnosis and Treatment
- Diet, Metabolism, and Disease
- Diabetes Treatment and Management
- Health Systems, Economic Evaluations, Quality of Life
- Dysphagia Assessment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Acute Ischemic Stroke Management
- Esophageal and GI Pathology
- Cardiovascular Disease and Adiposity
- Tracheal and airway disorders
- Venous Thromboembolism Diagnosis and Management
VASCage
2024-2025
Introduction: The progression of diabetes status in post-stroke patients remains under-investigated, particularly regarding new treatments for type II mellitus (DM II), like glucagon-like peptide 1 receptor agonists (GLP-1-RA) and sodium-glucose co-transporter-2 (SGLT-2) inhibitors, which have not been studied the setting. Patients methods: Eight hundred eighty-four consecutive ischemic stroke recruited to our prospective STROKE-CARD Registry were assessed concerning their glycemic at...
Background Women show higher age‐standardized mortality rates for ischemic stroke. Nevertheless, women are underrepresented in secondary stroke prevention trials. Our analysis investigated contributors to reduced study participation among a comprehensive center Austria. Methods The population‐based Tyrolean Stroke Pathway database was used describe sex distribution patients with the region and at site. Screening logs from 3 studies Medical University of Innsbruck were analyzed containing...
Aim To determine the prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) among Western Austrian adolescents and its association with arterial stiffness as a marker early vascular ageing. Methods In cross-sectional Early Vascular Ageing in YOUth study, fat content was assessed by controlled attenuation parameter (CAP) using signals acquired FibroScan (Echosense, Paris, France) 14- to 19-year-old adolescents. Arterial determined carotid-femoral pulse wave velocity...